Market Place
Sourcing Support
Blue Lake Biotech Reports Data For RSV Vaccine BLB201 In Kids
12 Dec 2024 //
BUSINESSWIRE
Blue Lake and CyanVac Present at Society for Vaccines Congress
21 Oct 2024 //
BUSINESSWIRE
Blue Lake Reports Positive Clinical Data in Children for Its RSV Vaccine
21 Mar 2024 //
BUSINESSWIRE
Phase 1 Data for Blue Lake Biotechnology’s Intranasal RSV Vaccine Published
25 Oct 2023 //
BUSINESSWIRE
Blue Lake Presenting at Upcoming BioFuture and BIO Investor Forum Conferences
27 Sep 2023 //
BUSINESSWIRE
Blue Lake to highlight preliminary COVID Phase 1 data at BIO CEO Conference
06 Feb 2023 //
PR NEWSWIRE
Blue Lake reports positive data from Phase I RSV vaccine trial
08 Nov 2022 //
CLINICALTRIALSARENA
Blue Lake Biotechnology Announces Positive Interim Phase 1 Data for BLB201
07 Nov 2022 //
PRNEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.